Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes-Reference-Cited by-同舟云学术

Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes

Published:2016-07-14 Issue:1 Volume:14 Page:23-36
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Thwala Lungile Nomcebo¹²,Préat Veronique²,Csaba Noémi Stefania¹

Affiliation:

1. Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Health Research Institute of Santiago de Compostela (IDIS), Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, Spain

2. Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Brussels, Belgium

Funder

Education, Audiovisual and Culture Executive Agency

European Commission

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2016.1206074

Reference99 articles.

1. Peptide therapeutics: Targeting the undruggable space